Plain-English translation of NCT07239310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Neuclare device, a medical device applied to the brain, to see if it can safely and temporarily improve your ability to plan and solve problems if you have mild cognitive impairment or very early Alzheimer's disease. You would continue taking your current cognitive medications while using the device. The study wants to understand whether this treatment, combined with your regular medication, can help with executive function—the thinking skills you use for planning and problem-solving.
People with early memory loss and Alzheimer's disease often struggle with planning and problem-solving abilities, even when taking medications. Researchers want to see if this new brain device could provide an additional benefit to help with these specific thinking skills.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will continue taking your regular cognitive medications. You will be randomly assigned to receive either the real Neuclare device or a sham (fake) device applied to your brain three times per week for four weeks. Throughout the trial, you will have assessments that measure your thinking abilities, daily functioning, brain imaging scans, blood tests, and quality of life. Neither you nor the study staff will know which treatment you're receiving until the study ends, which helps ensure fair results.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
South Korea